STK11 and prostate carcinoma: All three PIMs were later shown to phosphorylate and inhibit the upstream activating kinase for AMPK, liver kinase B1 (LKB1) on S334, relieving AMPK-mediated cellular growth arrest in breast (MCF7) and prostate cancer (PC3) cell lines [155].